Message Priming and Enrollment in, and Response to, a Smoking Cessation Program: A Pilot Study

Eligible participants will be 100 male \& female smokers aged 18-65, who smoke ≥ 10 cigarettes/day \& who plan to live in the area for the next 6-months. Key Exclusion Criteria Smoking Behavior 1.Use of chewing tobacco or snuff 2.Current enrollment or plans to enroll in another smoking cessation program in the next 6 months 3.Plan to use other nicotine substitutes or smoking cessation treatments in the next 6 months Alcohol/Drug Exclusion Criteria 1. History of substance abuse and/or currently receiving treatment for substance abuse 2. Current alcohol consumption that exceeds \>25 standard drinks/week Medication Exclusion Criteria 1. Current use or recent discontinuation (within last 14-days) of the following medications: 1. Any form of smoking cessation medication 2. Any form of anti-psychotic medications that includes: •antipsychotics, •atypical antipsychotics, •mood-stabilizers, •anti-depressants (tricyclics, SSRI's, MAOI's), •anti-panic agents, •anti-obsessive agents, •anti-anxiety agents, and * stimulants (e.g., Provigil, Ritalin). 3. Medication for chronic pain 4. Anti-coagulants 5. Any heart medications 6. Daily medication for asthma Medical Exclusion Criteria 1. Women who are pregnant, planning a pregnancy, or lactating. 2. History or current diagnosis of psychosis, major depression or bipolar disorder, schizophrenia, or any Axis 1 disorder. 3. Serious/unstable disease within the past 6 months (e.g., cancer \[but melanoma\], heart disease, HIV). 4. History of epilepsy or a seizure disorder. 5. History or current diagnosis (last 6-months) of abnormal rhythms and/or tachycardia (\>100 beats/minute); history or current diagnosis of COPD, cardiovascular disease (stroke, angina, coronary heart disease), heart attack in the last 6 months, uncontrolled hypertension (SBP\>150 or DBP\>90). 6. History of kidney and/or liver failure (including transplant). General Exclusion 1. Any medical condition or concomitant medication that could compromise participant safety or treatment, as determined by the Principal Investigator and/or Study Physician. 2. Inability to provide informed consent or complete any of the study tasks as determined by the Principal Investigator and/or Study Physician.